Saturday 17 October 2026
Export CVM’s income statement to Excel — free account
Cel-Sci Corporation
In the quarter to June 2026, EPS grew 65.4%, free cash flow fell 2.33% and total debt fell 39.7%, each against the same quarter a year earlier. Operating cash flow growth for three consecutive years; insiders bought in the last twelve months.
1.79
0.05
+2.87%
Follow CVM
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
| (252.53%) | (305.27%) | (212.12%) | (176.32%) |
+8 more TTM periods Free account |
|
| (108.91%) | (114.90%) | (97.99%) | (92.16%) | ||
ROIC |
(169.59%) | (147.48%) | (146.58%) | (145.08%) | |
Return on Tangible Assets |
(324.19%) | (719.09%) | (314.90%) | (202.56%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(1.38) | (2.05) | (2.12) | (4.23) | |
Free Cash Flow |
(16.75) | (16.65) | (17.00) | (17.16) | |
Capital Expenditures |
— | — | — | (0.04) | |
| Other line items | |||||
Cash ROIC |
(78.74%) | (126.20%) | (75.62%) | (52.64%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Inventory Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Days of Inventory on Hand |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
(50.19) | (43.92) | (41.09) | (38.23) | |
Operating CF/Net income |
0.74 | 0.73 | 0.71 | 0.67 | |
Depreciation/Fixed assets |
0.84 | 0.76 | 0.69 | 0.64 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | (0.01) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(1.38) | (2.05) | (2.12) | (4.22) | |
Capex per Share |
0.00 | 0.00 | 0.00 | (0.01) | |
Capex to Sales |
— | — | — | 0.00 |
Columns are period end dates